Loading news...
Premium Brands Holdings Corporation (PBH:CA) Q4 2025 Earnings Call Transcript
Prestige signed a deal to buy a portfolio of brands that includes the Breathe Right nasal strip from privately held Foundation Consumer Healthcare.
TARRYTOWN, N.Y., March 20, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced that it has entered into a definitive agreement to acquire the Breathe Right® brand and certain other brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at $150 million.
Premium Brands Holdings Corporation (PBH:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
These companies acquire established consumer brands with loyal customers, then improve margins and cash flow through efficiency efforts. Pet care, lawn and garden, and OTC healthcare products generate consistent demand, making these easy long-term wealth builders.
Bleakley Financial Group LLC purchased a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE: PBH) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 10,912 shares of the company's stock, valued at approximately $681,000. Several other hedge funds and
/PRNewswire/ -- Equity-Insider.com News Commentary - The global health and wellness sector is entering 2026 on a trajectory toward $6 trillion in annual
One profitable company whose shares we've held for years, and that demonstrates why a focus on shareholder value creation matters in the long run, is Old Republic International. A new mid-cap holding in the quarter was Prestige Consumer Healthcare, whose over-the-counter brands are familiar to many. A multi-year holding that has struggled recently is Watsco, the largest wholesale distributor of HVAC and refrigeration equipment in the United States.
Prestige Consumer Healthcare Inc. (NYSE: PBH - Get Free Report) has earned a consensus recommendation of "Hold" from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month target price
Prestige Consumer Healthcare Inc. (PBH) Q3 2026 Earnings Call Transcript
Prestige Consumer Healthcare (PBH) came out with quarterly earnings of $1.14 per share, missing the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.22 per share a year ago.
Premium Brands (PBH:CA) remains a 'Hold' with a price target near $110, reflecting market-like performance expectations into FY 2026. PBH's $10B revenue target hinges on organic growth and disciplined M&A, but high leverage and ongoing Capex constrain aggressive expansion. Organic volume growth outpaced pricing, driving a 19% sales jump, but EBITDA margins remain pressured by elevated beef costs and new plant overhead.
TARRYTOWN, N.Y., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and nine months ended December 31, 2025.
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Agilent Technologies (A). But which of these two companies is the best option for those looking for undervalued stocks?
TARRYTOWN, N.Y., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (the “Company” or “Prestige”) (NYSE: PBH) today announced it will issue its fiscal 2026 third quarter earnings release on Thursday, February 5, 2026 before the opening of the market.
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two stocks is more attractive to value investors?
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?
Prestige Consumer Healthcare benefits from e-commerce momentum, acquisitions and solid solvency, even as inflation and tariff costs pose near-term risks.
Prestige Consumer Healthcare (PBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors interested in stocks from the Medical - Products sector have probably already heard of Prestige Consumer Healthcare (PBH) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?